Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3).

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (muromonab-CD3). Ann Otol Rhinol Laryngol. 1997 Aug; 106(8):640-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.